Intestinal and Nasal Microbiota of Patients With Idiopathic Parkinson's Disease Trial N/A Completed Nov. 14, 2016
Deep Brain Stimulation of the Subthalamic Nucleus (STN) and Cognitive Control Trial N/A Completed Nov. 9, 2016
Study to Assess the Clinical Benefit and Safety of Droxidopa in Parkinson's Disease Trial Phase 2 Unknown Nov. 2, 2016
Nucleus Basalis Deep Brain Stimulation for Thinking & Memory Problems in Parkinson's. Trial Phase 1 Completed Oct. 30, 2016
Study Assessing Tolerability and Safety of AFFITOPE® PD03A in Patients With Early Parkinson's Disease Trial Phase 1 Completed Oct. 30, 2016
Measuring the Effects of Continuous Dopaminergic Stimulation on Nocturnal Movements in Parkinson's Disease Trial N/A Terminated Oct. 30, 2016
Parkinson's Disease Patient Study On Absorption, Distribution, Metabolism And Excretion Of Ropinirole Trial Phase 2 Completed Oct. 27, 2016
A Study to Compare Two Dose Strengths of CVT-301 (Levodopa Inhalation Powder) With an Oral Dose of Sinemet® (Carbidopa-levodopa) Tablets Trial Phase 1 Completed Oct. 25, 2016
Multiple Ascending Dose Study of PRX002 in Patients With Parkinson's Disease Trial Phase 1 Completed Oct. 20, 2016
Evaluation of Nalmefene in Impulse Control Disorders in Parkinson's Disease: A Prospective Open Label Study Trial Phase 2 Unknown Oct. 16, 2016
A Post Marketing Observational Study of Activities of Daily Living in Advanced Parkinson's Disease Patients With Early Troublesome Motor Fluctuations and Treated With Duodopa - a Multi-country Study Trial N/A Completed Oct. 12, 2016
Impact of Subthalamic Nucleus Deep Brain Stimulation on Pain in Parkinson Disease Trial N/A Completed Oct. 12, 2016
Satisfaction Survey on PINS Stimulator System for Patients With Parkinson's Disease Trial N/A Unknown Oct. 12, 2016
Evaluate the Safety and Effectiveness of Various Frequency Stimulation for Patients With Parkinson's Disease Trial Phase 2 Unknown Oct. 12, 2016
Clinical and Economic Impact of Duodopa: Long-term Effectiveness Study in Advanced Parkinson's Disease Patients Trial Phase 2 Completed Oct. 10, 2016